Dr. Renteria is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
120 Mineola Blvd
Ste 500
Mineola, NY 11501Phone+1 516-663-9500Fax+1 516-663-4613
Summary
- I am a board certified Hematologist Oncologist, specialized in Hematopoietic Cell Therapy & Adaptive Cell Therapy, GVHD, Adult Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Blood & Bone Marrow Transplant, 2012 - 2013
- Maimonides Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- NYC Health & Hospitals/South Brooklyn HealthChief Residency, Internal Medicine, 2008 - 2009
- NYC Health & Hospitals/South Brooklyn HealthResidency, Internal Medicine, 2006 - 2009
- Jackson Health SystemPost-Doctoral Fellowship, 2004 - 2005
- Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1996, MD, Cum Laude
Certifications & Licensure
- IN State Medical License 2024 - 2025
- MD State Medical License 2023 - 2025
- NJ State Medical License 2023 - 2025
- NY State Medical License 2012 - 2025
- DC State Medical License 2023 - 2024
- VA State Medical License 2022 - 2024
- LA State Medical License 2023 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Educational Commission for Foreign Medical GraduatesECFMG Certificate
- Join now to see all
Awards, Honors, & Recognition
- Reviewer Biology of Blood and Marrow Transplantation Journal
- Reviewer BMJ Case Reports Journal
- "Honor Your Doctor" Award The Mount Sinai Medical Center, New York, NY, 2013
- Join now to see all
Clinical Trials
- Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202) Start of enrollment: 2013 Jun 01
- Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease Start of enrollment: 2016 Aug 01
- A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Start of enrollment: 2017 Apr 28
- Join now to see all
Publications & Presentations
PubMed
- 489 citationsInternational, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.Andrew C. Harris, Rachel Young, Steven M. Devine, William J. Hogan, Francis Ayuk
Biology of Blood and Marrow Transplantation. 2016-01-01 - 136 citationsMAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHDHannah Major-Monfried, Anne S. Renteria, Attaphol Pawarode, Pavan Reddy, Francis Ayuk
Blood. 2018-06-21 - 13 citationsMultiple myeloma, race, insurance and treatmentHimanshu Joshi, Sylvia Lin, Kezhen Fei, Anne S. Renteria, Hannah Jacobs
Cancer Epidemiology. 2021-07-06
Books/Book Chapters
Abstracts/Posters
- Are we crazy? Building a successful acute leukemia and stem cell transplant program during the COVID-19 pandemicTaylor Harrison, MHA, Morgan Fillet, BS, RN, Anne S. Renteria, MD, James Williams, MHA, Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2022
- Implementation of an Acute Leukemia and Stem Cell Transplant Program through a Multidisciplinary Team Approach for Practice ChangeCassidy Smith, PA-C, Morgan Fillet, RN, BS, Martha Wright, PA-C, Julia Wuest, PA-C, Lauren Sheldon, BSN, RN, Kelsey Hawkins-Rusch, MS, RN, CNS, Maria Sbenghe, MD, Saad..., Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2022
- Dose-Adjusted Intensive Chemotherapy is Safe and Tolerable in Older Patients with Ph-Negative Acute Lymphoblastic LeukemiaRenteria AS, Venugopal S, Marcellino B, Keyzner A, Kremyanskaya M, Bar-Nathan M, Najfeld V, Mascarenhas J, Tandem Meeting, Houston, Texas, 2/23/2019
- Join now to see all
Lectures
- Twentv-Five Years of Advances in Hematology - Burham Lecture SeriesRochester Regional Hospital, Rochester, NY - 3/4/2021
- Achieving quality Cell and Gene Therapies outcomes through multidisciplinary collaborationICON's multidisciplinary approach to CGT clinical trials - Global Webinar - 9/24/2020
- Racial and insurance disparities in multiple myeloma management in a referral center.ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Join now to see all
Committees
- Member, BMT and Infectious Disease Committee - Mount Sinai Hospital 2017 - 2019
- Member, Takeda - Vedolizumab-GHD Advisory Board Meeting 2017 - 2017
- Member, Chemotherapy Council Committee - Mount Sinai Hospital 2016 - 2019
- Member, Ethics Committee at the Rio de Janeiro Medicine Council (CREMERJ) - University Hospital, Federal University of Rio de Janeiro, Brazil 2000 - 2001
- President, Association of Resident Physicians (AMERHU) - University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Brazil 1999 - 2000
Professional Memberships
- International Society Cell & Gene Therapy (ISCT)Member
- NEJM Catalyst Insights CouncilMember
- European Hematology AssociationMember
- Member
- Member
- Member
- American Society for Transplantation and Cellular Therapy (ASTCT)Member
Other Languages
- Portuguese, French, Spanish
External Links
- Acute Leukemiahttps://vimeo.com/642821327/bb6e8c6229
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: